1,246
Views
0
CrossRef citations to date
0
Altmetric
Original research

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma

, , , , , , , , , , , , , , , , , , ORCID Icon & show all
Article: 2267744 | Received 17 Aug 2023, Accepted 03 Oct 2023, Published online: 19 Oct 2023